about
Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffoldThe role of nuclear matrix proteins binding to matrix attachment regions (Mars) in prostate cancer cell differentiationAn intranuclear frame for chromatin compartmentalization and higher-order folding.Structural alterations of human serum albumin caused by glycative and oxidative stressors revealed by circular dichroism analysisSelection and characterization of single stranded DNA aptamers for the hormone abscisic Acid.Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins.Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids.A critical concentration of N-terminal pyroglutamylated amyloid beta drives the misfolding of Ab1-42 into more toxic aggregates.High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein.Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231, as possible mechanism of its neurotoxic effects.Conformation dependent pro-apoptotic activity of the recombinant human prion protein fragment 90-231.Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc.Organization of the lamin scaffold in the internal nuclear matrix of normal and transformed hepatocytes.Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.DNA supercoiling in apoptotic chromatin.A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity.Evidence of Molecular Interactions of Aβ1-42 with N-Terminal Truncated Beta Amyloids by NMR.SCN- binding to the charged lysines of histones end domains mimics acetylation and shows the major histone-DNA interactions involved in eu and heterochromatin stabilization.Multicomponent, fragment-based synthesis of polyphenol-containing peptidomimetics and their inhibiting activity on beta-amyloid oligomerization.Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications.Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells.beta-amyloid is different in normal aging and in Alzheimer disease.N-terminal truncated pyroglutamyl beta amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the full-length Abeta1-42.Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging ProbesEffects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and ToxicityEffect of ferric citrate on amyloid-beta peptides behaviorEthylene-co-Norbornene Copolymers Grafted Carbon Nanotube Composites by In Situ PolymerizationMicromorphological investigation on the leaves of the rock samphire (Crithmum maritimumL.): Occurrence of hesperidin and diosmin crystalsAttraction between Like-Charged Polyelectrolytes in the Extended Condensation Theory†Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxicBiophysical and in Vivo Studies Identify a New Natural-Based Polyphenol, Counteracting Aβ Oligomerization in Vitro and Aβ Oligomer-Mediated Memory Impairment and Neuroinflammation in an Acute Mouse Model of Alzheimer's DiseaseDesign and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold NanoparticlesMulticomponent Synthesis of Polyphenols and their in vitro Evaluation as Potential β-Amyloid Aggregation Inhibitors
P50
Q28584104-1624F512-21A5-4A72-9CB8-DCFE53ABE7B1Q34342174-5E1E3DCD-5FB5-4B48-88BF-B2DBD01BA4F6Q35014272-3A45EAE9-0C60-4DD9-B0B5-EA3AB2FA867EQ37007052-11EAB4F8-2746-4E5B-933B-3D483369BF09Q37139585-479617F0-66C7-4FAA-94A6-ADA38FAE585CQ38475218-28112D74-37D9-44C1-895A-F6A9307EE052Q39295233-DB7A2F3B-AC0E-464B-97F3-E0F1BBF96D6EQ39424641-4C3F13C4-1680-4EB4-9BEF-61BEC46A084DQ39629223-E715F623-5B18-4278-B635-4EB1AF1324D4Q40066046-302CF5BD-B3C8-4426-B6ED-2461B877AE33Q40257029-EEC20A5E-05B0-4C92-AAEB-D4F8EB10C010Q40465567-9A8B3240-A678-4705-B609-C46980B8F293Q43212695-AD465385-14FC-46FB-8C52-0007D579F676Q44158602-A5184C2A-C506-49FB-81DC-858D42F415F7Q44577792-7EAF1A10-3551-4D15-B975-7FD2E5E7FD6FQ45357282-3550CBF6-41C1-41A7-95F0-759A22228A0DQ46425947-F7986EEE-9008-4D7E-AAED-0DC2883DEE55Q46775371-5B8D50F6-9CB6-49C6-8219-CE8C6A737230Q47583431-BAFFF7E8-9693-4225-828E-7F52978564DEQ52576382-D9DFF67E-0AF7-4C5A-9814-4A94549488D3Q52714326-57AFFC7F-041F-4034-BE2A-20DF70A11C1BQ53271609-52388B67-68CE-4DBC-8A3C-6B542B4437D2Q53402168-2299A2F1-30BA-4D42-B858-C42D6199A9F7Q58308014-C2AFC685-FD59-4E39-814C-F866F8030B93Q59220911-10A9F45D-4DA1-4FE6-8DCD-0D38CA84590FQ59220914-D5371A7A-3198-481A-BED7-170AC5044BF9Q59220923-5EE117B2-B77B-45C8-80D1-3075B8596FD2Q59220936-0E3B4F72-FA24-4C68-94DB-E3FBFFD38BD7Q59220940-4D4D9027-E428-4A70-97D8-72979BFCA46BQ59220955-4E8CF579-E427-4894-ADE3-ED863D908171Q90653949-27E7A26C-EB54-4A5D-B0DB-818A787EEF5BQ90845998-90A0CBC4-4F24-4BE4-92EB-5533B07A29F5Q92084454-3094FC65-B7D1-457D-A52A-15B856F10FB9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cristina D'Arrigo
@ast
Cristina D'Arrigo
@en
Cristina D'Arrigo
@es
Cristina D'Arrigo
@nl
Cristina D'Arrigo
@sl
type
label
Cristina D'Arrigo
@ast
Cristina D'Arrigo
@en
Cristina D'Arrigo
@es
Cristina D'Arrigo
@nl
Cristina D'Arrigo
@sl
prefLabel
Cristina D'Arrigo
@ast
Cristina D'Arrigo
@en
Cristina D'Arrigo
@es
Cristina D'Arrigo
@nl
Cristina D'Arrigo
@sl
P106
P1153
7003874583
P21
P31
P496
0000-0002-5352-5287